The Brd4 Extraterminal Domain Confers Transcription Activation Independent of pTEFb by Recruiting Multiple Proteins, Including NSD3
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Bromodomain protein 4 (Brd4) plays critical roles in development, cancer progression, and virus-host pathogenesis. To gain mechanistic insight into the various biological functions of Brd4, we performed a proteomic analysis to identify and characterize Brd4-associated cellular proteins. We found that the extraterminal (ET) domain, whose function has to date not been determined, interacts with NSD3, JMJD6, CHD4, GLTSCR1, and ATAD5. These ET-domain interactions were also conserved for Brd2 and Brd3, the other human BET proteins tested. We demonstrated that GLTSCR1, NSD3, and JMJD6 impart a pTEFb-independent transcriptional activation function on Brd4. NSD3 as well as JMJD6 is recruited to regulated genes in a Brd4-dependent manner. Moreover, we found that depletion of Brd4 or NSD3 reduces H3K36 methylation, demonstrating that the Brd4/NSD3 complex regulates this specific histone modification. Our results indicate that the Brd4 ET domain through the recruitment of the specific effectors regulates transcriptional activity. In particular, we show that one of these effectors, NSD3, regulates transcription by modifying the chromatin microenvironment at Brd4 target genes. Our study thus identifies the ET domain as a second important transcriptional regulatory domain for Brd4 in addition to the carboxyl-terminal domain (CTD) that interacts with pTEFb.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“N-terminal bromodomains confer binding to acetylated histone H3 and H4 tails, while the C-terminal extraterminal domain interacts with chromatin modifying enzymes such as histone methyltransferase NSD3 (REF.119,120).”
From Structure and function of retroviral integrase (2022) · cites this paper as [120]
Citations
Cites
High-Resolution Profiling of Histone Methylations in the Human Genome
Barski, A., Cuddapah, S., Cui, K., Roh, T.-Y., Schones, D. E., Wang, Z., Wei, G., Chepelev, I., & Zhao, K. (2007) · Cell · doi:10.1016/j.cell.2007.05.009 · Cited by 6,845 · cited 1×
“H3K36me3 levels were higher within the coding region, peaking at the 3 end, than at the promoter in accordance with published findings (2).”
ResultDefining the Human Deubiquitinating Enzyme Interaction Landscape
Sowa, M. E., Bennett, E. J., Gygi, S. P., & Harper, J. W. (2009) · Cell · doi:10.1016/j.cell.2009.04.042 · Cited by 1,512
Self-citationCarrozza, M. J., Li, B., Florens, L., Suganuma, T., Swanson, S. K., Lee, K. K., Shia, W.-J., Anderson, S., Yates, J., Washburn, M. P., et al. (2005) · Cell · doi:10.1016/j.cell.2005.10.023 · Cited by 1,294 · cited 1×
“Studies ranging from yeast to humans suggest that methylated H3K36 is enriched in regions of active transcription and is linked to transcriptional elongation and productive transcription within coding regions (5, 48, 49, 53).”
BackgroundJang, M. K., Mochizuki, K., Zhou, M., Jeong, H.-S., Brady, J. N., & Ozato, K. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.027 · Cited by 1,291 · cited 3×
“Many different BET family members, including the yeast bdf1/bdf2, Drosophila fs(1)h, and the mammalian Brd2, Brd3, and Brd4 proteins, have been implicated in transcription regulation (11, 13, 24, 27, 32).”
BackgroundRecruitment of P-TEFb for Stimulation of Transcriptional Elongation by the Bromodomain Protein Brd4
Yang, Z., Yik, J. H. N., Chen, R., He, N., Jang, M. K., Ozato, K., & Zhou, Q. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.029 · Cited by 1,138 · cited 2×
“However, only the CTD, present solely in Brd4 and fs(1)h, has been rigorously documented to regulate transcription through its interaction with pTEFb (4, 24, 56).”
BackgroundXue, Y., Wong, J., Moreno, G. T., Young, M. K., Côté, J., & Wang, W. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80299-3 · Cited by 985 · cited 1×
“CHD4 was observed to interact with components of the NuRD corepressor complex also as predicted previously (54).”
BackgroundJMJD6 Is a Histone Arginine Demethylase
Chang, B., Chen, Y., Zhao, Y., & Bruick, R. K. (2007) · Science · doi:10.1126/science.1145801 · Cited by 745 · cited 1×
“It was initially reported to be a histone arginine demethylase, responsible for H3R2me and H4R3me modifications (6).”
BackgroundControl of Inducible Gene Expression by Signal-Dependent Transcriptional Elongation
Hargreaves, D. C., Horng, T., & Medzhitov, R. (2009) · Cell · doi:10.1016/j.cell.2009.05.047 · Cited by 644 · cited 2×
“A recent study demonstrates that transcription of primary responsive genes in stimulated macrophages is dependent on Brd4 and is linked to production of mature spliced transcripts (19).”
BackgroundBRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma.
French, C. A., Miyoshi, I., Kubonishi, I., Grier, H. E., Pérez‐Atayde, A. R., & Fletcher, J. A. (2003) · PubMed · Cited by 501
The human Mi-2/NuRD complex and gene regulation
Denslow, S. A., & Wade, P. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210611 · Cited by 478 · cited 1×
“Notably, evidence suggests that it is involved in repression of genes that are regulated by estrogen receptor (12).”
Background
Research works printed but not linked: 2
- Denis G. V., 2000, Cell Growth Differ, 11, 417
- French C. A., 2003, Cancer Res, 63, 304
Cited by
Items 201–300 of 554
SERPINB2 is regulated by dynamic interactions with pause-release proteins and enhancer RNAs
Shii, L., Li, S., Maurer, K., Zhang, Z., & Sullivan, K. E. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.05.005 · Cited by 50
“To escape pausing, BRD4 recruits P-TEFb by binding to acetylated histones (Rahman et al., 2011; Dey et al., 2003).”
Luna-Peláez, N., March‐Díaz, R., Ceballos-Chávez, M., Guerrero-Martinez, J. A., Grazioli, P., García‐Gutiérrez, P., Vaccari, T., Massa, V., Reyes, J. C., & García‐Domínguez, M. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1792-x · Cited by 49
Tsume-Kajioka, M., Kimura-Yoshida, C., Mochida, K., Shibukawa, Y., Amazaki, S., Wada, Y., Hiramatsu, R., Shimokawa, K., & Matsuo, I. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.149 · Cited by 48
Structural Mechanism of the Oxygenase JMJD6 Recognition by the Extraterminal (ET) Domain of BRD4
Konuma, T., Yu, D., Zhao, C., Ju, Y., Sharma, R., Ren, C., Zhang, Q., Zhou, M., & Zeng, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-16588-8 · Cited by 47
Olp, M. D., Sprague, D. J., Goetz, C. J., Kathman, S. G., Wynia‐Smith, S. L., Shishodia, S., Summers, S. B., Xu, Z., Statsyuk, A. V., & Smith, B. C. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00058 · Cited by 47
Interplay of condensation and chromatin binding underlies BRD4 targeting
Strom, A. R., Eeftens, J. M., Polyachenko, Y., Weaver, C. J., Watanabe, H.-F., Bracha, D., Orlovsky, N. D., Jumper, C. C., Jacobs, W. M., & Brangwynne, C. P. (2024) · Molecular Biology of the Cell · doi:10.1091/mbc.e24-01-0046 · Cited by 50
“The full-length BRD4 DNA fragment was amplified by PCR from pcDNA4-TO-HA-BRD4FL (Addgene plasmid #31351) (Rahman et al. , 2011) incorporated into linearized FM5 lentiviral vectors containing standardized linkers (generously provided by David Sanders) using the In-Fusion HD cloning kit (Takara Bio,…”
MethodJumonji domain‐containing protein 6 protein and its role in cancer
Yang, J., Chen, S., Yang, Y., Ma, X., Shao, B., Yang, S., Wei, Y., & Wei, X. (2020) · Cell Proliferation · doi:10.1111/cpr.12747 · Cited by 48
Progress in the Discovery of Small-Molecule Inhibitors of Bromodomain–Histone Interactions
Chung, C., & Witherington, J. J. (2011) · SLAS DISCOVERY · doi:10.1177/1087057111421372 · Cited by 48
“although a body of literature suggests a role of Bet proteins in the life cycle of infectious agents, including human immunodeficiency virus (hiV), herpes, and papilloma viruses,(23,24) both the bromodomains and the et (extra-terminal) regions have been implicated in transcriptional regulation.(25) therefore, the ther…”
BackgroundGarcía-Cuéllar, M.-P., Büttner, C., Bartenhagen, C., Dugas, M., & Slany, R. K. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.018 · Cited by 45
Control of Stimulus-Dependent Responses in Macrophages by SWI/SNF Chromatin Remodeling Complexes
Gatchalian, J., Liao, J., Maxwell, M. B., & Hargreaves, D. C. (2020) · Trends in Immunology · doi:10.1016/j.it.2019.12.002 · Cited by 46
“Alpsoy A and Dykhuizen EC (2018) Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes.”
BackgroundInfluentialBromodomains: a new target class for small molecule drug discovery
Chung, C., & Tough, D. F. (2012) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2011.12.002 · Cited by 54
Jang, M. K., Anderson, D. E., Doorslaer, K. V., & McBride, A. A. (2015) · PROTEOMICS · doi:10.1002/pmic.201400613 · Cited by 44
“Examples of these are ATAD5 [25], the replication factor (RFC) complex [26], WHSC1 [27], and WHSC1L1 (NSD3) [25].”
BackgroundInfluentialYAP condensates are highly organized hubs
Hao, S., Lee, Y. J., Goldfajn, N. B., Flores, E., Liang, J., Fuehrer, H., Demmerle, J., Lippincott‐Schwartz, J., Liu, Z. J., Sukenik, S., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109927 · Cited by 44
“43,44 Previously, it was shown that TAZ condensates formed after the overexpression of TAZ can enrich BRD4.”
CREB Promotes Beta Cell Gene Expression by Targeting Its Coactivators to Tissue-Specific Enhancers
de Velde, S. V., Wiater, E., Tran, M. A., Hwang, Y., Cole, P. A., & Montminy, M. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00200-19 · Cited by 53
“Notably, superenhancers are acutely sensitive to inhibitors of the BET/bromodomain protein BRD4, a chromatin reader that links histone acetylation to the release of paused Pol II and to its productive elongation over the gene body (17).”
BackgroundThe poly(ADP-ribosyl)ation of BRD4 mediated by PARP1 promoted pathological cardiac hypertrophy
Li, Z., Guo, Z., Lan, R., Cai, S., Lin, Z., Li, J., Wang, J., Li, Z., & Liu, P. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.12.012 · Cited by 43
Histone Acetylation and Modifiers in Renal Fibrosis
Shen, F., & Zhuang, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.760308 · Cited by 49
Current Understanding of the Role of the Brd4 Protein in the Papillomavirus Lifecycle
McBride, A. A., & Jang, M. K. (2013) · Viruses · doi:10.3390/v5061374 · Cited by 42
“Thus, Brd4 has the potential to assemble multifaceted positive and negative regulatory complexes on promoters [71].”
BackgroundBRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
Kurata, K., Samur, M., Liow, P., Wen, K., Yamamoto, L., Liu, J., Morelli, E., Gullà, A., Tai, Y., Qi, J., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-3668 · Cited by 41
“GLTSCR1 interacts with BRD4 to regulate the transcriptional elongation of target genes (53 – 55).”
BackgroundBrd2 Gene Disruption Causes “Metabolically Healthy” Obesity
Wang, F., Deeney, J. T., & Denis, G. V. (2013) · Vitamins and hormones · doi:10.1016/b978-0-12-407766-9.00003-1 · Cited by 49
“The amino-terminal dual bromodomains in this family are followed by an " extraterminal " domain that is involved in protein–protein interactions (Lin et al., 2008; Rahman et al., 2011), thus the " BET " family name.”
BackgroundSengupta, S., Biarnes, M. C., Clarke, R. C., & Jordan, V. C. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3319-1 · Cited by 45
“BET proteins, particularly BRD4, are known to interact with PTEFb [37,11], and positively influence transcription by RNAP.”
InfluentialIntrinsic Disorder of the BAF Complex: Roles in Chromatin Remodeling and Disease Development
Hadidy, N. E., & Uversky, V. N. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215260 · Cited by 42
Luo, W., Stevens, T. M., Stafford, P., Miettinen, M., Gatalica, Z., & Vranić, S. (2021) · Current Oncology · doi:10.3390/curroncol28060381 · Cited by 44
“BRD4, complexed with other proteins including BRD3, NSD3, and ZNF through its extraterminal domain [73], further recruits positive transcription elongation factor (pTEFb) by its CTD and activates pTEFb by displacing the negative regulators of pTEFb.”
BackgroundColeman, D. J., Gao, L., Schwartzman, J. A., Korkola, J. E., Sampson, D., Derrick, D. S., Urrutia, J. A., Balter, A. I., Burchard, J., King, C. J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-40518-5 · Cited by 41
Liu, S., Li, F., Pan, L., Yang, Z., Shu, Y., Lv, W., Dong, P., & Gong, W. (2019) · Cancer Science · doi:10.1111/cas.14102 · Cited by 39
The Essential Transcriptional Function of BRD4 in Acute Myeloid Leukemia
Roe, J., & Vakoc, C. R. (2016) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2016.81.031039 · Cited by 46
Pinz, S., Unser, S., Buob, D., Fischer, P., Jobst, B., & Rascle, A. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv188 · Cited by 37
“Beside their interaction with factors regulating transcription, BET proteins interact with chromatin remodeling complexes and regulate the maintenance of higher-order chromatin structure (81,83,86).”
BackgroundXia, L., Liu, J., Zheng, Z., Chen, Y.-J., Ding, J., Hu, Y.-H., Hu, G.-S., Xia, N., & Liu, W. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.05.019 · Cited by 38
“BRD4 is a member of the bromodomain and extraterminal (BET) subfamily of human bromodomain proteins, which is associated with acetylated chromatin to facilitate transcriptional activation.(15,16) BRD4 co-occupies thousands of enhancers, among which a small set are super-enhancers.”
BackgroundBET bromodomain inhibitors in leukemia
Basheer, F., & Huntly, B. J. P. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.06.004 · Cited by 41
The Role of Bromodomain and Extraterminal Motif (BET) Proteins in Chromatin Structure
Hsu, S. C., & Blobel, G. A. (2017) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2017.82.033829 · Cited by 44
“Proteomics studies have shown that BETs reside in nuclear complexes with chromatin-modifying enzymes (Dawson et al. 2011; Rahman et al. 2011) such as histone methyltransferases and chromatin remodeling machinery.”
BackgroundDual-target Inhibitors Based on BRD4: Novel Therapeutic Approaches for Cancer
Zhang, S., Chen, Y., Tian, C., He, Y., Tian, Z., Wan, Y., & Liu, T. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200610174453 · Cited by 43
Hu, Y., Belaghzal, H., Hsiao, W., Qi, J., Bradner, J. E., Guertin, D. A., Sif, S., & Imbalzano, A. N. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv645 · Cited by 39
“Although we did not identify any interaction of JMJD6 with BRD2 and BRD3 at the time point we assayed in the differentiating cells by co-immunoprecipitation (Supplementary Figure S9), since JMJD6 potentially interacts with both BRD2 and BRD4 (15,51), it is possible that JMJD6 collaborates with these distinct chromatin…”
Pleiotrophin antagonizes Bromodomain-containing protein 2 (Brd2) during neuronal differentiation
Garcia-Gutierrez, P., Juarez-Vicente, F., Wolgemuth, D. J., & Garcia-Dominguez, M. (2014) · Journal of Cell Science · doi:10.1242/jcs.147462 · Cited by 35
“Reported interactions of Brd2 with several chromatin co-regulators through the ET domain (Rahman et al., 2011) raise the question of how these factors may alter Ptn function or interaction.”
BackgroundFarrell, A., Alahari, S., Ermini, L., Tagliaferro, A., Litvack, M. L., Post, M., & Caniggia, I. (2019) · JCI Insight · doi:10.1172/jci.insight.127009 · Cited by 40
Strategies for Targeting Retroviral Integration for Safer Gene Therapy: Advances and Challenges
Yoder, K. E., Rabe, A. J., Fishel, R. A., & Larue, R. C. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.662331 · Cited by 41
Mondal, A., Swapna, G. V. T., López, M. M., Klang, L., Hao, J., Ma, L.-C., Roth, M. J., Montelione, G. T., & Pérez, A. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c01595 · Cited by 39
Chemically induced degradation of epigenetic targets
Kabir, M., Yu, X., Kanıskan, H. Ü., & Jin, J. J. (2023) · Chemical Society Reviews · doi:10.1039/d3cs00100h · Cited by 38
Jumonji Domain Containing Protein 6: A Novel Oxygen Sensor in the Human Placenta
Alahari, S., Post, M., & Caniggia, I. (2015) · Endocrinology · doi:10.1210/en.2015-1262 · Cited by 37
“The p6352 MSCV-CMV-CMV-Flag-HA-JMJD6 plasmid was obtained from Addgene (Plasmid 31358) (31) in a DH5a Escherichia coli strain of bacteria.”
BackgroundBET-inhibition by JQ1 promotes proliferation and self-renewal capacity of hematopoietic stem cells
Wroblewski, M., Scheller, M., Udonta, F., Bauer, R., Schlichting, J., Zhao, L., Batalla, I. B., Gensch, V., Päsler, S., Wu, L., et al. (2018) · Haematologica · doi:10.3324/haematol.2017.181354 · Cited by 36
“In addition, BRD4 contains other protein domains such as an extra-terminal domain, the function of which is not influenced by JQ1.(27) Although the effect of JQ1 described in our study most likely results from the increased number of HSC, other data link it to increased HSC fitness.”
BackgroundKregel, S., Malik, R., Asangani, I. A., Wilder-Romans, K., Rajendiran, T. M., Xiao, L., Vo, J. N., Soni, T., Cieslik, M. P., Fernández‐Salas, E., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3776 · Cited by 38
“In addition to acting as critical coactivators for AR-mediated gene transcription, BRD2/3/4 function to facilitate transcriptional activation of many transcription factors by increasing their effective molarity on the chromatin through interactions with acetylated histones and RNA polymerase II (RNA Pol-II) transcript…”
BackgroundAiyer, S., Swapna, G. V. T., Ma, L.-C., Liu, G., Hao, J., Chalmers, G., Jacobs, B. C., Montelione, G. T., & Roth, M. J. (2021) · Structure · doi:10.1016/j.str.2021.01.010 · Cited by 35
Luo, J., Bishop, J. A., DuBois, S. G., Hanna, G. J., Sholl, L. M., Stelow, E. B., Thompson, L. D. �., Shapiro, G. I., & French, C. A. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-00986-3 · Cited by 36
Widespread hydroxylation of unstructured lysine-rich protein domains by JMJD6
Cockman, M. E., Sugimoto, Y., Pegg, H. B., Masson, N., Salah, E., Tumber, A., Flynn, H. R., Kirkpatrick, J. M., Schofield, C. J., & Ratcliffe, P. J. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2201483119 · Cited by 35
Yu, L., Wang, Z., Zhang, Z., Ren, X., Lu, X., & Ding, K. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150302110135 · Cited by 34
Markowski, M. C., Marzo, A. M. D., & Antonarakis, E. S. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1393518 · Cited by 35
Transcriptional networks in acute myeloid leukemia
Thoms, J. A. I., Beck, D., & Pimanda, J. E. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22794 · Cited by 34
Modulation of BRD4 in HIV epigenetic regulation: implications for finding an HIV cure
Alamer, E., Zhong, C., Hajnik, R. L., Soong, L., & Hu, H. (2021) · Retrovirology · doi:10.1186/s12977-020-00547-9 · Cited by 34
“Via the acetyl-lysine (KAc) binding pocket in BDs, BRD4 binds to acetylated-histones in chromatin and serves as a scaffolding platform for recruiting a spectrum of partner proteins through the PPI via domains such as ET, CTD (c-terminal domain), and PID (p-TEF-interacting domain).”
BackgroundInfluentialAlsarraj, J., & Hunter, K. W. (2011) · International Journal of Breast Cancer · doi:10.1155/2012/670632 · Cited by 37
“Here, we will focus on the role that the metastasis susceptibility gene Brd4 plays in the regulation of extracellular matrix (ECM) gene expression and subsequently metastatic progression.”
BackgroundBET proteins in abnormal metabolism, inflammation, and the breast cancer microenvironment
Andrieu, G. P., Shafran, J. S., Deeney, J. T., Bharadwaj, K. R., Rangarajan, A., & Denis, G. V. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.5ri0917-380rr · Cited by 35
Turberfield, A. H., Kondo, T., Nakayama, M., Koseki, Y., King, H. W., Koseki, H., & Klose, R. J. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz607 · Cited by 36
“…of histone H3K36, NSD1-3 and ASH1L, the main H3K36me1/2 methyltransferases, can associate with gene promoters and genic regions, and H3K36me2 blankets most of the genome (Gregory et al. 2007; Lucio-Eterovic et al. 2010; Kuo et al. 2011; Rahman et al. 2011; Ram et al. 2011; Shen et al. 2015).”
BackgroundBromodomain inhibitors regulate the C9ORF72 locus in ALS
Zeier, Z. R., Esanov, R., Belle, K. C., Volmar, C., Johnstone, A. L., Halley, P., DeRosa, B. A., Khoury, N., van Blitterswijk, M., Rademakers, R., et al. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.06.017 · Cited by 36
Rare ATAD5 missense variants in breast and ovarian cancer patients
Kostovska, I. M., Wang, J., Bogdanova, N. V., Schürmann, P., Bhuju, S., Geffers, R., Dürst, M., Liebrich, C., Klapdor, R., Christiansen, H., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.03.048 · Cited by 34
Lee, S., Liu, H., Hill, R. C., Chen, C., Hong, X., Crawford, F., Kingsley, M. C., Zhang, Q., Liu, X., Chen, Z., et al. (2020) · eLife · doi:10.7554/elife.53930 · Cited by 33
ARID1A Mutation in Metastatic Breast Cancer: A Potential Therapeutic Target
Cheng, X., Zhao, J., Dong, F., & Cao, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.759577 · Cited by 33
Du, C., Jin, Y., Qi, J.-J., Ji, Z.-X., Li, S., An, G., Jia, H., & Ni, J. (2012) · Molecules and Cells · doi:10.1007/s10059-012-2286-1 · Cited by 34
“These effectors regulate transcription by modifying the chromatin microenvironment at Brd4 target genes (Rahman et al., 2011).”
BackgroundTwist-BRD4 Complex: Potential Drug Target for Basal-like Breast Cancer
Shi, J., Cao, J., & Zhou, B. P. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666141211153853 · Cited by 35
“extra-terminal (ET) domain of BRD4 (59, 60).”
BRD4: an effective target for organ fibrosis
Wei, Q., Gan, C., Sun, M., Xie, Y., Liu, H., Xue, T., Deng, C., Mo, C., & Ye, T. (2024) · Biomarker Research · doi:10.1186/s40364-024-00641-6 · Cited by 34
“BET proteins mainly recruit TFs or other specific proteins through the ET structural domain to coregulate the transcription of target genes [83, 84].”
BackgroundHIV latency reversing agents act through Tat post translational modifications
Khoury, G., Mota, T. M., Li, S., Tumpach, C., Lee, M. Y.-H., Jacobson, J. C., Harty, L., Anderson, J. L., Lewin, S. R., & Purcell, D. F. J. (2018) · Retrovirology · doi:10.1186/s12977-018-0421-6 · Cited by 32
“Besides its role in transcriptional elongation, the bromodomain protein BRD4 is involved in alternative splicing regulation as it interacts with JMJD6 (JmjC domain containing protein 6) that mediates 5′ hydroxylation of U2AF65, a major component of the spliceosomal complex important for 3′ splice site recognition [53,…”
BackgroundOu‐Yang, F., Pan, M., Chang, S., Wu, C., Fang, S., Li, C.-L., Hou, M., & Luo, C. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116963 · Cited by 32
Dissecting the Role of BET Bromodomain Proteins BRD2 and BRD4 in Human NK Cell Function
Cribbs, A. P., Filippakopoulos, P., Philpott, M., Wells, G., Penn, H., Oerum, H., Valge-Archer, V., Feldmann, M., & Oppermann, U. C. T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.626255 · Cited by 32
“Furthermore, BRD4 can independently recruit transcriptional activators, such as NSD3, JMJD6 and CHD4 to remodel chromatin (51).”
BackgroundLiu, Z., Piao, L., Zhuang, M., Qiu, X., Xu, X., Zhang, D., Liu, M., & Ren, D. (2017) · Oncology Reports · doi:10.3892/or.2017.5936 · Cited by 31
“NSD3 was reported as a translocation partner of NuP98 in an AML patient associated with t(8;11)(p11.”
BackgroundCompromised JMJD6 Histone Demethylase Activity Affects VHL Gene Repression in Preeclampsia
Alahari, S., Post, M., Rolfo, A., Weksberg, R., & Caniggia, I. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02197 · Cited by 34
“The JMJD6 WT plasmid (p6352 MSCV-CMV-CMV-FlagHA-JMJD6) was obtained from Addgene [plasmid 31358 (19); Cambridge, MA].”
MethodBromodomains: A novel target for the anticancer therapy
Gokani, S., & Bhatt, L. K. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174523 · Cited by 33
PCNA Unloading Is Negatively Regulated by BET Proteins
Kang, M.-S., Kim, J., Ryu, E., Ha, N. Y., Hwang, S., Kim, B., Ra, J. S., Kim, Y. J., Hwang, J. M., Myung, K., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.114 · Cited by 31
Protein lysine acetylation and its role in different human pathologies: a proteomic approach
Morales-Tarré, O., Alonso-Bastida, R., Arcos-Encarnación, B., Pérez‐Martínez, L., & Encarnación‐Guevara, S. (2021) · Expert Review of Proteomics · doi:10.1080/14789450.2021.2007766 · Cited by 32
“The extra-terminal domain gives independent pTEFb transcription activation through specific effector recruitment and functions as an additional regulatory domain of BET protein transcription [74].”
BackgroundViral E protein neutralizes BET protein-mediated post-entry antagonism of SARS-CoV-2
Chen, I. P., Longbotham, J. E., McMahon, S., Suryawanshi, R. K., Khalid, M. M., Taha, T. Y., Tabata, T., Hayashi, J. M., Soveg, F. W., Carlson-Stevermer, J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111088 · Cited by 30
“…fide reader domains of acetylated lysines in histone and non-histone proteins and are the molecular targets of small-molecule BET inhibitors such as JQ1, whereas the ET domain has less defined protein binding properties (Dhalluin et al., 1999; Filippakopoulos et al., 2012; Rahman et al., 2011).”
Super-enhancer-driven lncRNA LIMD1-AS1 activated by CDK7 promotes glioma progression
Chen, Z., Tian, D., Chen, X., Cheng, M., Xie, H., Zhao, J., Liu, J., Fang, Z., Zhao, B., & Bian, E. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05892-z · Cited by 32
“As a highly specific covalent inhibitor of CDK7, THZ1 represses transcription by decreasing CDK7-dependent Pol II CTD phosphorylation [50, 51].”
BackgroundMethylation of BRD4 by PRMT1 regulates BRD4 phosphorylation and promotes ovarian cancer invasion
Liu, Y., Liu, H., Ye, M., Jiang, M., Chen, X., Song, G., Ji, H., Wang, Z. P., & Zhu, X. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06149-5 · Cited by 30
“Notably, the expression of phospho-Smad2 and phospho-Smad4 was signi fi - cantly decreased in A2780 cells after PRMT1 knockdown (Fig.”
Chromatin targeting drugs in cancer and immunity
Prinjha, R. K., & Tarakhovsky, A. (2013) · Genes & Development · doi:10.1101/gad.221895.113 · Cited by 30
“…domain-containing histone methyltransferase), JMJD6 (a histone arginine demethylase), and CHD4 (a catalytic component of the NuRD nucleosome remodeling complex) points to active BET involvement in chromatin modifications that might be required for transcriptional elongation (Rahman et al. 2011).”
BackgroundBET bromodomain inhibitors—A novel epigenetic approach in castration-resistant prostate cancer
Lochrin, S. E., Price, D. K., & Figg, W. D. (2014) · Cancer Biology & Therapy · doi:10.4161/15384047.2014.962297 · Cited by 29
“Members of the bromodomain and extra-terminal (BET) subfamily of human bromodomain proteins (BRD 2, 3, and 4) associate with acetylated chromatin and facilitate transcriptional activators.(9) Recent research has established compelling evidence for targeting BRD 4 in cancer, elucidating a novel epigenetic approach for…”
BackgroundReciprocal control of translation and transcription in autism spectrum disorder
Longo, F., & Klann, E. (2021) · EMBO Reports · doi:10.15252/embr.202052110 · Cited by 30
Cornelia de Lange syndrome-associated mutations cause a DNA damage signalling and repair defect
Olley, G., Pradeepa, M. M., Grimes, G. R., Piquet, S., Polo, S. E., FitzPatrick, D. R., Bickmore, W. A., & Boumendil, C. (2021) · Nature Communications · doi:10.1038/s41467-021-23500-6 · Cited by 29
Design, synthesis and biological evaluation of dihydroquinoxalinone derivatives as BRD4 inhibitors
Yang, Y., Zhao, L., Xu, B., Yang, L., Zhang, J., Zhang, H., & Zhou, J. (2016) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2016.08.009 · Cited by 29
Ren, W., Wang, C., Wang, Q., Zhao, D., Zhao, K., Sun, D., Liu, X., Han, C., Hou, J., Li, X., et al. (2017) · Scientific Reports · doi:10.1038/srep39986 · Cited by 30
Saettone, A., Garg, J., Lambert, J., Nabeel‐Shah, S., Ponce, M., Burtch, A., Mudalige, C. T., Gingras, A., Pearlman, R. E., & Fillingham, J. (2018) · Epigenetics & Chromatin · doi:10.1186/s13072-018-0180-6 · Cited by 28
“The ET domains in contrast are thought to recruit effector proteins which in turn can regulate the transcriptional activity [37].”
Importance of a crystalline water network in docking-based virtual screening: a case study of BRD4
Zhong, H., Wang, Z., Wang, X., Liu, H., Li, D., Liu, H., Yao, X., & Hou, T. (2019) · Physical Chemistry Chemical Physics · doi:10.1039/c9cp04290c · Cited by 28
Malvezzi, F., Stubbs, C. J., Jowitt, T. A., Dale, I. L., Guo, X., DeGnore, J. P., Degliesposti, G., Skehel, M. J., Bannister, A. J., & McAlister, M. S. B. (2021) · Communications Biology · doi:10.1038/s42003-021-02750-6 · Cited by 30
“These compounds were found to 20 efficiently displace both BRD4 isoform A (1-1362) (FL) and isoform C (1-722) from histone 21 H3 in NanoBRET assays with a much lower IC50 than the monovalent I-BET (Fig.”
BackgroundMethodThe Oncoprotein BRD4-NUT Generates Aberrant Histone Modification Patterns
Zee, B. M., DiBona, A., Alekseyenko, A. A., French, C. A., & Kuroda, M. I. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163820 · Cited by 28
“Though we focused solely on BRD4-NUT in this report, future research should also determine whether other NMC fusion proteins, such as BRD3-NUT, NSD3-NUT, and even other BRD4-NUT proteins with different fusion junctions, enrich for similar modifications [25, 27–29].”
BackgroundWerner, M. T., Wang, H., Hamagami, N., Hsu, S. C., Yano, J. A., Stonestrom, A. J., Behera, V., Zong, Y., Mackay, J. P., & Blobel, G. A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010679 · Cited by 28
“For example, ATAD5, CHD8, SMARCA4/BRG1, WHSC1/NSD2, WHSC1L1/NSD3, and CDK9 (5, 7, 8, 16, 46) were enriched significantly by both the ET and ETCC domains (Fig.”
BackgroundNagasawa, M., Tomimatsu, K., Terada, K., Kondo, K., Miyazaki, K., Miyazaki, M., Motooka, D., Okuzaki, D., Yoshida, T., Kageyama, S., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.03.043 · Cited by 28
BRD9 is a druggable component of interferon-stimulated gene expression and antiviral activity
Börold, J., Eletto, D., Busnadiego, I., Mair, N. K., Moritz, E., Schiefer, S., Schmidt, N., Petric, P. P., Wong, W. W.-L., Schwemmle, M., et al. (2021) · EMBO Reports · doi:10.15252/embr.202152823 · Cited by 27
“In addition, our proteomic experiments confirmed the previously described interaction of BRD4 with the ncBAF complex (Rahman et al , 2011; Alpsoy & Dykhuizen, 2018; Gatchalian et al , 2018), and BRD4 can mediate the recruitment of ncBAF subunits to chromatin in a bromodomain-dependent manner…”
Martella, N., Pensabene, D., Varone, M., Colardo, M., Petraroia, M., Sergio, W., Rosa, P. L., Moreno, S., & Segatto, M. (2023) · Biomedicines · doi:10.3390/biomedicines11030750 · Cited by 31
“Indeed, its ETD can bind SWI-SNF and CHD2 which are responsible for ATP-dependent chromatin remodeling [6,50].”
BackgroundZhao, C., Zhang, Y., Zhang, J., Li, S., Liu, M.-Y., Geng, Y., Liu, F., Chai, Q., Meng, H., Li, M., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01242 · Cited by 27
Huang, Q.-X., Fan, D.-M., Zheng, Z., Ran, T., Bai, A., Xiao, R.-Q., Hu, G.-S., & Liu, W. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00141 · Cited by 27
Clinical impact of molecular features in diffuse large B-cell lymphoma and follicular lymphoma
Pon, J. R., & Marra, M. A. (2015) · Blood · doi:10.1182/blood-2015-07-658401 · Cited by 26
Ras-Induced miR-146a and 193a Target Jmjd6 to Regulate Melanoma Progression
Anelli, V., Ordas, A., Kneitz, S., Muñoz‐Sagredo, L., Gourain, V., Schartl, M., Meijer, A. H., & Mione, M. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00675 · Cited by 26
“It would be interesting to study whether antipause enhancers, which are the substrates of the JMJD6-Brd4 interaction, are associated with pro-oncogenic gene expression in melanoma.”
BackgroundInfluentialHan, Y., Lindner, S., Bei, Y., García, H. D., Timme, N., Althoff, K., Odersky, A., Schramm, A. R., Lissat, A., Künkele, A., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2018.12.012 · Cited by 28
Targeting the medulloblastoma: a molecular-based approach.
Luzzi, S., Lucifero, A. G., Brambilla, I., Mantelli, S. S., Mosconi, M., Foiadelli, T., & Savasta, S. (2020) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v91i7-s.9958 · Cited by 31
Emerging roles of BET proteins in transcription and co‐transcriptional RNA processing
Eischer, N., Arnold, M., & Mayer, A. (2022) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1734 · Cited by 32
Short Hairpin RNA Screen Reveals Bromodomain Proteins as Novel Targets in Acute Myeloid Leukemia
Blobel, G. A., Kalota, A., Sanchez, P. V., & Carroll, M. P. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.08.019 · Cited by 26
“Brd4 is recruited to acetylated histones and stimulates transcriptional elongation, but recent results suggest the protein may play a role in a variety of chromatin regulating complex (Rahman et al., 2011).”
BackgroundJacques-Fricke, B. T., & Gammill, L. S. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-12-0744 · Cited by 27
“NSD proteins bind promoters (Lucio-Eterovic et al., 2010; Kuo et al., 2011; Rahman et al., 2011) and contain a domain believed to mediate nonhistone protein interactions unique to each NSD family member (He et al.”
BackgroundInfluentialNSD family proteins: Rising stars as therapeutic targets
He, L., Cao, Y., & Sun, L. (2024) · Cell Insight · doi:10.1016/j.cellin.2024.100151 · Cited by 25
“Studies have also shown that the BET (bromodomain and extraterminal) protein BRD4, which binds acetylated histones, can recruit NSD3 to chromatin, and BRD4 depletion results in reduced NSD3-catalyzed H3K36 methylation (Rahman et al., 2011).”
BackgroundHistone and DNA binding ability studies of the NSD subfamily of PWWP domains
Zhang, M., Yang, Y., Zhou, M., Dong, A., Yan, X., Loppnau, P., Min, J., & Liu, Y. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.07.017 · Cited by 24
Yin, Y., Liu, W., Shen, Q., Zhang, P., Wang, L., Tao, R., Li, H., Ma, X., Zeng, X., Cheong, J., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0833 · Cited by 26
Kim, S.-K., Liu, X., Park, J., Um, D., Kilaru, G., Chiang, C., Kang, M., Huber, K. M., Kang, K., & Kim, T.-K. (2021) · Science Advances · doi:10.1126/sciadv.abf7346 · Cited by 24
“The ubiquitously expressed BET proteins may work redundantly and/or coordinately as they exhibit overlapping genomicbinding profiles at active genes (12, 21) and associate with many common transcriptional regulators (8, 13, 22).”
BackgroundInfluentialLindén, M., Vannas, C., Österlund, T., Andersson, L., Osman, A. A. M., Escobar, M., Fagman, H., Ståhlberg, A., & Åman, P. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13195 · Cited by 23
Bromodomain-Containing Protein BRD4 Is Hyperphosphorylated in Mitosis
Wang, R., Yang, J. F., Ho, F., Robertson, E. S., & You, J. (2020) · Cancers · doi:10.3390/cancers12061637 · Cited by 25
JMJD6 participates in the maintenance of ribosomal DNA integrity in response to DNA damage
Fages, J., Chailleux, C., Humbert, J., Jang, S.-M., Loehr, J., Lambert, J., Côté, J., Trouche, D., & Canitrot, Y. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008511 · Cited by 23
“Importantly, JMJD6 influences transcription [31].”
Mann, M. W., Roberts, D. S., Zhu, Y., Li, Y., Zhou, J., Ge, Y., & Brasier, A. R. (2021) · Viruses · doi:10.3390/v13030454 · Cited by 23
“CDK12 was 300 likewise unaffected by bromodomain inhibition, which is consistent with the interaction 301 mechanism of the related CDK9 protein, which interacts with BRD4 via its C-terminal 302 domain rather than its bromodomains [57].”
BackgroundDonczew, R., & Hahn, S. (2021) · eLife · doi:10.7554/elife.69619 · Cited by 23
“The bromodomain and extra-terminal domain (BET) family is characterized by the presence of a double BD, which has the highest affinity towards hyperacetylated histone H4, and an ET domain that interacts with nonhistone proteins (Rahman et al., 2011; Slaughter et al., 2021).”
Shiota, H., Alekseyenko, A. A., Wang, Z. A., Filic, I., Knox, T. M., Luong, N. M., Huang, Y., Scott, D. A., Jones, K. L., Gokhale, P. C., et al. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0259 · Cited by 25
“While the BRD4 moiety binds acetylated histones through its dual bromodomains (15, 16) and recruits numerous protein interactors through its ET domain (12, 17), NUT serves to recruit p300 and activate its catalytic histone acetyltransferase (HAT) domain (10, 13, 18, 19).”
Background
Metadata
- Authors
- Rahman, S., Sowa, M. E., Ottinger, M., Smith, J. A., Shi, Y., Harper, J. W., & Howley, P. M.
- Affiliations
- Harvard University (US)
- Corresponding author
- Howley, Peter M.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2011-07-01
- Volume
- 31
- Issue
- 13
- Pages
- 2641-2652
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC3133372
- OpenAlex
- W2167732604
- Cited by
- 532
- References
- 60
- Citations by year
- 2026: 25 · 2025: 14 · 2024: 41 · 2023: 39 · 2022: 35 · 2021: 55 · 2020: 37 · 2019: 41 · 2018: 39 · 2017: 42 · 2016: 40 · 2015: 30 · 2014: 27 · 2013: 33 · 2012: 27
- FWCI
- 12.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Molecular and Cellular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (AG011085, R01AG011085)
- National Cancer Institute (T32CA009361, R01CA116720)
- National Institute of General Medical Sciences (GM054137, R01GM054137, R01GM070565)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- BRD4, NSD3, JMJD6, ATAD5, CHD4, H3K36 methylation, chromatin recruitment, BET proteins, BRD2, BRD3, protein-protein interaction, histone modifications
- MeSH terms
- Bromodomain Containing Proteins, Amino Acid Sequence, Cell Line, Chromosomal Proteins, Non-Histone, Humans, Molecular Sequence Data, Nuclear Proteins, Histone-Lysine N-Methyltransferase, Transcription Factors, Transcriptional Activation, Protein Structure, Tertiary, Cell Cycle Proteins, Tumor Suppressor Proteins, Positive Transcriptional Elongation Factor B, Jumonji Domain-Containing Histone Demethylases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.